DongsiLuMDPhD
Pathology • Chesterfield, MODermatopathology, Anatomic Pathology, Clinical Pathology
Pathologist, St Luke's Hospital
Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
232 S Woodsmill Rd
Chesterfield, MO 63017Phone+1 314-205-6506Fax+1 314-205-6830- Is this information wrong?
Summary
- Dr. Dongsi Lu is a pathologist in Chesterfield, MO and is affiliated with St. Luke's Hospital. She received her medical degree from Beijing Medical University and has been in practice 16 years. She specializes in dermatopathology, anatomic pathology, and clinical pathology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Dermatopathology, 2003 - 2004- Washington University/B-JH/SLCH Consortium Surgical PathologyFellowship, Selective Pathology, 2002 - 2003
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1998 - 2002
Beijing Medical UniversityClass of 1991
Certifications & Licensure
MO State Medical License 2004 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 9 citationsNatriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis.Mohamed A. Zayed, Scott D Harring, Dana R. Abendschein, Chandu Vemuri, Dongsi Lu, Lisa Detering, Yongjian Liu, Pamela K. Woodard> ;Journal of Medical & Surgical Pathology. 2016 Jul 5
- 4 citationsProliferative activity in melanocytic nevi from patients grouped by age with clinical follow-up.Dongsi Lu, Ethan Levin, Louis P. Dehner, Anne C. Lind> ;Journal of Cutaneous Pathology. 2015 Nov 17
- 14 citationsHistopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma.Kari E. Sufficool, Donna M. Hepper, Gerald P. Linette, Eva A. Hurst, Dongsi Lu, Anne C. Lind, Lynn A. Cornelius> ;Journal of Cutaneous Pathology. 2014 Jul 1
- Join now to see all
Hospital Affiliations
St. Luke's HospitalChesterfield, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
